AGTC Joins the My Retina Tracker Program as a New Scientific Collaborator

UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), Blueprint Genetics, and Foundation Fighting Blindness, announced that AGTC, a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, will join the My Retina Tracker Program as a new scientific collaborator to enhance the development of its investigational gene therapies for inherited retinal diseases (IRDs).

The My Retina Tracker Program, a collaboration between Blueprint Genetics, Foundation Fighting Blindness, and InformedDNA, is an open access, no-cost program that offers individuals with IRDs easy access to high-quality genetic diagnostics and genetic counseling. This program has become one of the largest volume genetic testing initiatives for IRDs globally.

Learn more about AGTC Joins the My Retina Tracker Program as a New Scientific Collaborator.